Global Protein-based Multiplex Assays Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Protein-based Multiplex Assays Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Multiplex assay is a procedure in which various analytes (such as proteins, biomolecules, growth factors, cytokines, chemokines, and others) are profiled by detecting and quantifying them simultaneously. This assay is used to amplify multiple targets in a polymerase chain reaction (PCR) and collect more information from minute quantities of proteins or other analytes in lesser time as compared to conventional methods such as ELISA. Multiplex assays are widely used for pathogen identification, mutation analysis, RNA detection, gene detection analysis, linkage analysis, forensic studies, and others.
Protein-based Multiplex Assays report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Protein-based Multiplex Assays market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Companion Diagnostics and Research & Development are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Protein-based Multiplex Assays industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Protein-based Multiplex Assays key companies include Luminex, Thermo Fisher Scientific, Illumina, Bio-Rad Lab, QIAGEN, BD, Abcam, Seegene and Meso Scale Diagnostics, etc. Luminex, Thermo Fisher Scientific, Illumina are top 3 players and held % share in total in 2022.
Protein-based Multiplex Assays can be divided into Reagents & Consumables, Instruments & Accessories and Software & Services,, etc. Reagents & Consumables is the mainstream product in the market, accounting for % share globally in 2022.
Protein-based Multiplex Assays is widely used in various fields, such as Companion Diagnostics, Research & Development and Clinical Diagnostics,, etc. Companion Diagnostics provides greatest supports to the Protein-based Multiplex Assays industry development. In 2022, global % share of Protein-based Multiplex Assays went into Companion Diagnostics filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Protein-based Multiplex Assays market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Luminex
Thermo Fisher Scientific
Illumina
Bio-Rad Lab
QIAGEN
BD
Abcam
Seegene
Meso Scale Diagnostics
Randox Laboratories
Segment by Type
Reagents & Consumables
Instruments & Accessories
Software & Services
Companion Diagnostics
Research & Development
Clinical Diagnostics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Protein-based Multiplex Assays market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Protein-based Multiplex Assays introduction, etc. Protein-based Multiplex Assays Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Protein-based Multiplex Assays market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Protein-based Multiplex Assays report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Protein-based Multiplex Assays market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Companion Diagnostics and Research & Development are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Protein-based Multiplex Assays industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Protein-based Multiplex Assays key companies include Luminex, Thermo Fisher Scientific, Illumina, Bio-Rad Lab, QIAGEN, BD, Abcam, Seegene and Meso Scale Diagnostics, etc. Luminex, Thermo Fisher Scientific, Illumina are top 3 players and held % share in total in 2022.
Protein-based Multiplex Assays can be divided into Reagents & Consumables, Instruments & Accessories and Software & Services,, etc. Reagents & Consumables is the mainstream product in the market, accounting for % share globally in 2022.
Protein-based Multiplex Assays is widely used in various fields, such as Companion Diagnostics, Research & Development and Clinical Diagnostics,, etc. Companion Diagnostics provides greatest supports to the Protein-based Multiplex Assays industry development. In 2022, global % share of Protein-based Multiplex Assays went into Companion Diagnostics filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Protein-based Multiplex Assays market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Luminex
Thermo Fisher Scientific
Illumina
Bio-Rad Lab
QIAGEN
BD
Abcam
Seegene
Meso Scale Diagnostics
Randox Laboratories
Segment by Type
Reagents & Consumables
Instruments & Accessories
Software & Services
Segment by Application
Companion Diagnostics
Research & Development
Clinical Diagnostics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Protein-based Multiplex Assays market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Protein-based Multiplex Assays introduction, etc. Protein-based Multiplex Assays Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Protein-based Multiplex Assays market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.